Rychik, Jack http://orcid.org/0000-0001-8625-6565
Goldberg, David J.
Rand, Elizabeth
Mancilla, Edna E.
Heimall, Jennifer
Seivert, Nicholas
Campbell, Danielle
O’Malley, Shannon
Dodds, Kathryn M.
Article History
Received: 22 January 2022
Accepted: 28 April 2022
First Online: 23 May 2022
Change Date: 13 June 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00246-022-02952-7
Conflict of interest
: Dr. Goldberg is a named inventor on method of use patents regarding the use of udenafil in patients who have undergone Fontan palliation. Dr. Rychik is a consultant for Mezzion Pharmaceuticals, a company in search of solutions for challenges in the single ventricle population.